Table 3.
Likely prognostic significance of 1x clinical dose mean maximum or peak placebo-corrected effects on QTc interval.
| Mean maximum or peak placebo-corrected increase in QTc interval | Likely potential torsadogenic risk |
|---|---|
| ≤5 ms | None |
| 6–10 ms | Unlikely |
| 11–15 ms | Possible |
| 16–20 ms | Probable |
| 21–25 ms | Almost definite |
| ≥26 ms | Definite |